ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,164.12
-0.19%
Dow Jones
39,027.81
-0.35%
Gold vs US Dollar
2,326.38
-0.06%
Brent Oil
84.765
-0.76%
Bitcoin
60,683.83
-1.50%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. NeuroSense Therapeutics Ltd (NRSNW) Share Price

NRSNW NeuroSense Therapeutics Ltd

0.206
0.0274 (15.34%)
Last Updated: 19:27:25
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 NeuroSense Therapeutics Ltd NASDAQ:NRSNW NASDAQ Equity Warrant  Warrant
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.0274 15.34 0.206 0.15 0.225 0.2352 0.206 0.2185 11,400 18:27:25   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -11.28M -0.7335 -0.30 3.38M
 Type  Size  Price  Time  Units 
  1,000 0.206 18:27:23 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore NRSNW News
17/06/202422:25EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
17/06/202422:24EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
17/06/202422:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
28/05/202412:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
23/05/202421:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
23/05/202405:15EDGAR2Form EFFECT - Notice of Effectiveness
22/05/202422:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
Period
Draw mode
Data Downloads for NRSNW

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest NeuroSense Therapeutics Ltd Articles